# BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures $5.3 Million from Warrant Exercises to Advance AVERSA Fentanyl NDA

Nutriband (NASDAQ: NTRB), a company developing abuse deterrent pharmaceutical products, announced the exercise of warrants at a strike price of $6.43, generating $5,306,000 in proceeds. The funds will support the remaining clinical development of AVERSA Fentanyl and submission of its New Drug Application (NDA) with the U.S. Food and Drug Administration. AVERSA Fentanyl, which could become the world’s first opioid patch with abuse deterrent properties, is estimated to reach peak annual U.S. sales of $80 million to $200 million, according to a 2022 Health Advances market analysis report.

 To view the full press release, visit https://ibn.fm/7olqo

 About Nutriband Inc.

 We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA(TM) abuse-deterrent technology. AVERSA(TM) technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

 NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

 About BioMedWire

 BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

 BMW is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit https://www.BioMedWire.com

 Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

 BioMedWireAustin, Texaswww.BioMedWire.com512.354.7000 OfficeEditor@BioMedWire.com

 BioMedWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/bmw/biomednewsbreaks-nutriband-inc-nasdaq-ntrb-secures-5-3-million-from-warrant-exercises-to-advance-aversa-fentanyl-nda/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/nutriband-secures-5-3m-to-advance-world-s-first-abuse-deterrent-fentanyl-patch/45202677511f01ffbe63ac01e2c054ba) 


Pickup - [https://burstable.news/news](https://burstable.news/news/202509/196355-nutriband-inc-secures-5-3-million-through-warrant-exercises-to-advance-aversa-fentanyl-nda-submission)

Pickup - [https://estallarnoticias.com/](https://estallarnoticias.com//202509/196372-nutriband-inc-recauda-53-millones-mediante-ejercicio-de-warrants-para-impulsar-desarrollo-de-aversa-fentanyl)

Pickup - [https://platzennachrichten.de/nachrichten](https://platzennachrichten.de/nachrichten/202509/196551-nutriband-inc-sichert-53-millionen-us-dollar-durch-optionsscheinausubungen-fur-aversa-fentanyl-nda)

Pickup - [https://actueclair.com](https://actueclair.com/202509/196494-nutriband-inc-leve-53-millions-de-dollars-pour-accelerer-le-developpement-de-son-patch-anti-abus-de-fentanyl-aversa)
 



[Reddit Post](https://www.reddit.com/r/HealthCareNewsInfo/comments/1n8hdde/nutriband_secures_53m_to_advance_worlds_first/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/259/4/paleqYch.webp)